Skip to main content

Advertisement

Log in

The Results of Sentinel Node Mapping for Patients with Clinically Early Staged Gastric Cancer Diagnosed with pT2/deeper Tumors

  • Original Scientific Report
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Sentinel node (SN) mapping based on the SN concept has been applied to early gastric cancer. However, it is still controversial whether or not the oncological safety is ensured in case pathological stage was advanced in these patients. The aim of this study was to investigate the validity of SN mapping in patients with clinically early staged gastric cancer diagnosed with pT2/deeper tumors.

Methods

We retrospectively analyzed 40 patients with a diagnosis of cT1N0 or cT2N0 single-lesion gastric cancer who were shown to have pT2 or deeper tumors after gastrectomy with SN mapping. We adopted a dual-tracer method using a radioactive colloid and blue dye to detect SNs. The diagnostic accuracy and distribution of SNs at each tumor site were analyzed.

Results

Of the 40 patients, 24 (60%) were postoperatively diagnosed as pT2, and 16 (40%) as pT3 or T4. SNs were detected in all patients. The false negative rate was 9% (1/11), and in that patient, the non-SN metastasis was observed within the SN basin. Diagnostic accuracy was 98% (39/40). Overall distribution of SNs was similar to that for patients with early gastric cancer. No significant differences in overall and recurrence-free survival were observed between the patients who underwent standard gastrectomy and those who underwent function-preserving gastrectomy, based on the results of SN mapping.

Conclusions

Our results confirmed validity of SN mapping for patients with clinically early staged gastric cancer diagnosed with pT2/deeper tumors after gastrectomy. Closed surveillance without additional surgical treatment is an option for these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

p:

Pathological

SN:

Sentinel node

LN:

Lymph node

OS:

Overall survival

RFS:

Recurrence-free survival

References

  1. Wong JHCL, Morton DL (1991) Lymphatic drainage of skin to a sentinel lymph node in a feline model. Ann Surg 214:637–641

    Article  CAS  Google Scholar 

  2. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK et al (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392–399

    Article  CAS  Google Scholar 

  3. Giuliano AE, Kirgan DM, Guenther JM, Morton DL (1994) Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391–398

    Article  CAS  Google Scholar 

  4. Kitagawa Y, Takeuchi H, Takagi Y, Natsugoe S, Terashima M, Murakami M et al (2013) Sentinel node mapping for gastric cancer: A prospective multicenter trial in Japan. J Clin Oncol 31:3704–3710

    Article  Google Scholar 

  5. Niihara M, Takeuchi H, Nakahara T, Saikawa Y, Takahashi T, Wada N et al (2016) Sentinel lymph node mapping for 385 gastric cancer patients. J Surg Res 200:73–81

    Article  Google Scholar 

  6. Miwa K, Kinami S, Taniguchi K, Fushida S, Fujimura T, Nonomura A (2003) Mapping sentinel nodes in patients with early-stage gastric carcinoma. Br J Surg 90:178–182

    Article  CAS  Google Scholar 

  7. Morita D, Tsuda H, Ichikura T, Kimura M, Aida S, Kosuda S et al (2007) Analysis of sentinel node involvement in gastric cancer. Clin Gastroenterol Hepatol 5:1046–1052

    Article  Google Scholar 

  8. Kitagawa Y, Fujii H, Mukai M, Kubota T, Otani Y, Kitajima M (2002) Radio-guided sentinel node detection for gastric cancer. Br J Surg 89:604–608

    Article  CAS  Google Scholar 

  9. Takeuchi M, Takeuchi H, Kawakubo H, Kitagawa Y (2018) Update on the indications and results of sentinel node mapping in upper GI cancer. Clin Exp Metastasis 35:455–461

    Article  CAS  Google Scholar 

  10. Kim YW, Baik YH, Yun YH, Nam BH, Kim DH, Choi IJ et al (2008) Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial. Ann Surg 248:721–727

    Article  Google Scholar 

  11. Seevaratnam R, Cardoso R, McGregor C, Lourenco L, Mahar A, Sutradhar R et al (2011) How useful is preoperative imaging for tumor, node, metastasis (TNM) staging of gastric cancer? A meta-analysis Gastric Cancer 15:3–18

    Article  Google Scholar 

  12. Japanese Gastric Cancer Association (2021) Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer 24:1–21

    Article  Google Scholar 

  13. Sobin L, Gospodarowicz MWC (eds) (2009) TNM Classification of Malignant Tumours, 7th edn. Wiley-Liss, New York

    Google Scholar 

  14. Gastric Cancer Association (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14:101–112

    Article  Google Scholar 

  15. Kinami S, Fujimura T, Ojima E, Fushida S, Ojima T, Funaki H et al (2008) PTD classification: proposal for a new classification of gastric cancer location based on physiological lymphatic flow. Int J Clin Oncol 13:320–329

    Article  Google Scholar 

  16. Mayanagi S, Takahashi N, Mitsumori N, Arigami T, Natsugoe S, Yaguchi Y et al (2020) Sentinel node mapping for post-endoscopic resection gastric cancer: multicenter retrospective cohort study in Japan. Gastric Cancer. https://doi.org/10.1007/s10120-019-01038-3

    Article  PubMed  PubMed Central  Google Scholar 

  17. Takeuchi M, Takeuchi H, Kawakubo H, Shimada A, Nakahara T, Mayanagi S et al (2019) Risk factors for lymph node metastasis in non-sentinel node basins in early gastric cancer: sentinel node concept. Gastric Cancer 22:223–230

    Article  Google Scholar 

  18. Santos FA, Drummond-Lage AP, Rodrigues MA, Cabral AM, Pedrosa MS, Braga H et al (2016) Sentinel node biopsy using blue dye and technetium99 in advanced gastric cancer: anatomical drainage and clinical application. Braz J Med Biol Res. https://doi.org/10.1590/1414-431x20165341

    Article  PubMed  PubMed Central  Google Scholar 

  19. Bara T, Gurzu S, Jung I, Borz C, Banias L, Bara T (2019) Sentinel node biospy using intravital blue dye. Medicine (Baltimore) 98:e14951

    Article  CAS  Google Scholar 

  20. Yano K, Nimura H, Mitsumori N, Takahashi N, Kashiwagi H, Yanaga K (2012) The efficiency of micrometastasis by sentinel node navigation surgery using indocyanine green and infrared ray laparoscopy system for gastric cancer. Gastric Cancer 15:287–291

    Article  Google Scholar 

  21. Yamashita K, Sakuramoto S, Nemoto M et al (2011) Trend in gastric cancer: 35 years of surgical experience in Japan. World J Gastroenterol 17:3390–3397

    Article  Google Scholar 

  22. Haruta S, Shinohara H, Hosogi H, Ohkura Y, Kobayashi N, Mizuno A et al (2017) Proximal gastrectomy with exclusion of no. 3b lesser curvature lymph node dissection could be indicated for patients with advanced upper-third gastric cancer. Gastric Cancer 20:528–35

    Article  Google Scholar 

  23. Sato Y, Katai H, Ito M, Otsuki S, Yamagata Y, Morita S (2018) Can proximal gastrectomy be justified for advanced adenocarcinoma of the esophagogastric junction? J Gastric Cancer 18:339–347

    Article  Google Scholar 

  24. Takeuchi H, Oyama T, Kamiya S, Nakamura R, Takahashi T, Wada N et al (2011) Laparoscopy-assisted proximal gastrectomy with sentinel node mapping for early gastric cancer. World J Surg 35:2463–2471. https://doi.org/10.1007/s00268-011-1223-3

    Article  PubMed  Google Scholar 

  25. Ahn HS, Lee HJ, Yoo MW, Kim SG, Im JP, Kim SH et al (2009) Diagnostic accuracy of T and N stages with endoscopy, stomach protocol CT, and endoscopic ultrasonography in early gastric cancer. J Surg Oncol 99:20–27

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank Kumiko Motooka, who is a staff member at the Department of Surgery in the Keio University School of Medicine, for her help in the preparation of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hirofumi Kawakubo.

Ethics declarations

Conflict of interest

Dr. Kitagawa reports grants and personal fees from AsahiKASEI Co., Ltd., grants and personal fees from TAIHO PHARMACEUTICAL CO., LTD, grants and personal fees from CHUGAI PHARMACEUTICAL CO., LTD., grants from DAIICHI SANKYO COMPANY, LIMITED, grants from Merck Serono Co., Ltd., grants and personal fees from EA Pharma Co., Ltd., grants and personal fees from Yakult Honsha Co. Ltd., grants and personal fees from Otsuka Pharmaceutical Co., Ltd., grants from Takeda Pharmaceutical Co., Ltd., grants and personal fees from Otsuka Pharmaceutical Factory Inc., grants and personal fees from SHIONOGI & CO., LTD., grants from KAKEN PHARMACEUTICAL CO.,LTD., grants from Kowa Pharmaceutical Co., Ltd., grants and personal fees from Astellas Pharma Inc., grants from MEDICON INC., grants and personal fees from DAINIPPON SUMITOMO PHARMA Co., Ltd., grants and personal fees from Taisho Toyama Pharmaceutical Co., Ltd., grants from Kyouwa Hakkou Kirin Co., Ltd., grants from Pfizer Japan Inc., grants and personal fees from ONO PHARMACEUTICAL CO., LTD., grants and personal fees from NIHON PHARMACEUTICAL CO., LTD., grants from Japan Blood Products Organization, grants from Medtronic Japan Co., Ltd., grants and personal fees from Sanofi K.K., grants from Eisai Co., Ltd., grants from TSUMURA & CO., grants from KCI Licensing, Inc., grants from ABBOTT JAPAN CO., LTD., grants from FUJIFILM Toyama Chemical Co., Ltd., outside the submitted work;.

Ethical Approval

All procedures were followed in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and within the requirements of the 1964 Declaration of Helsinki and later versions. Informed consent or substitute for it was obtained from all patients included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PPTX 193 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Takeuchi, M., Kawakubo, H., Shimada, A. et al. The Results of Sentinel Node Mapping for Patients with Clinically Early Staged Gastric Cancer Diagnosed with pT2/deeper Tumors. World J Surg 45, 3350–3358 (2021). https://doi.org/10.1007/s00268-021-06254-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-021-06254-6

Navigation